Advertisement

Sulfonylurea monotherapy ups CVD risk vs. metformin in older diabetics

Published on: 

Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.

Advertisement
Advertisement